1. Home
  2. CRGO vs EDSA Comparison

CRGO vs EDSA Comparison

Compare CRGO & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freightos Limited Ordinary shares

CRGO

Freightos Limited Ordinary shares

HOLD

Current Price

$1.23

Market Cap

66.7M

Sector

Finance

ML Signal

HOLD

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

HOLD

Current Price

$5.25

Market Cap

56.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRGO
EDSA
Founded
2012
2015
Country
Spain
Canada
Employees
382
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.7M
56.1M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CRGO
EDSA
Price
$1.23
$5.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$2.40
$5.00
AVG Volume (30 Days)
55.8K
61.8K
Earning Date
05-26-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.61
N/A
Revenue Next Year
$16.85
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$0.72
52 Week High
$4.24
$20.32

Technical Indicators

Market Signals
Indicator
CRGO
EDSA
Relative Strength Index (RSI) 42.22 33.37
Support Level $1.17 $4.87
Resistance Level $1.45 $6.58
Average True Range (ATR) 0.10 0.52
MACD 0.02 -0.12
Stochastic Oscillator 26.11 4.53

Price Performance

Historical Comparison
CRGO
EDSA

About CRGO Freightos Limited Ordinary shares

Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters, thousands of forwarders, and dozens of airlines and ocean carriers. The company operates in two segments: the Platform segment and the Solutions segment. The majority of the revenue is derived from the Solutions segment, which provides software tools and data to help industry participants automate their pricing, sales, and procurement processes. Geographically, it generates the maximum revenue from Europe, and the rest from the United States, Hong Kong and Others.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: